During this study, a universal protocol and standard operating procedures were developed in collaboration with the Centre for Colorectal Disease in an attempt to standarise pathological diagnosis and treatment of all CRC based on tumour type (colon or rectal) taking account of the patient’s MMR and BRAF status (supplementary document). This evidence concerns the gene MRC1 and colorectal carcinoma.